Stocks Telegraph

MNMD Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:MNMD

Mind Medicine (MindMed) Inc.

$5.25
-0.32-5.75%
At Close 4:00 PM
63.25
BESG ScoreESG Rating

MNMD eps in a glimpse

Growth Next 5yrs
N/A
Last Quarter
-$0.48
Past Year
-$2.26
Growth Past 5yrs
2.29%
Next Quarter
-$0.28
Estimate Next Year
$16.97

Analyst Rating Consensus

33

Ratings

12Strong Buy
21Buy
0Hold
0Sell
0Strong Sell
Buy

MNMD Price Target

Highest Price Target

$75.00

(

NaN% Upside

)

Mean Price Target

$28.61

(

413.57% Upside

)

Lowest Price Target

$3.00

(

-46.14% Downside

)

MNMD Price Target History

DatePrice TargetRating StatusRatingFirm
2024-08-2935.0 → 55.0MaintainsBuyHC Wainwright & Co.
2024-07-31NoneReiteratesBuy → BuyHC Wainwright & Co.
2024-07-2436.0 → 36.0MaintainsBuyRoth MKM
2024-06-21NoneReiteratesOverweightCantor Fitzgerald
2024-05-2827.0InitiatesOutperformBaird
2024-05-1329.0 → 20.0ReiteratesOutperform → OutperformOppenheimer
2024-05-1075.0 → 35.0MaintainsBuyHC Wainwright & Co.
2024-04-1520.0InitiatedOutperformLeerink Partners
2023-12-059.0InitiatedBuyCanaccord Genuity
2023-08-227.0ReiteratesOverweight → OverweightCantor Fitzgerald
2023-08-0475.0ReiteratesBuyHC Wainwright & Co.
2023-06-2875.0 → 75.0ReiteratesBuy → BuyHC Wainwright & Co.
2023-06-21NoneReiteratesOutperform → OutperformRBC Capital
2023-06-2021.0ReiteratesBuy → BuyEF Hutton
2023-05-1821.0ReiteratesBuy → BuyEF Hutton
2023-05-0975.0ReiteratesBuyHC Wainwright & Co.
2023-05-0521.0ReiteratesBuyEF Hutton
2023-04-1875.0ReiteratesBuyHC Wainwright & Co.
2023-04-1422.0ReiteratesOutperformOppenheimer
2023-03-1675.0ReiteratesBuyHC Wainwright & Co.
2023-03-105.0ReiteratesOutperformRBC Capital
2023-01-1975.0ReiteratesBuyHC Wainwright & Co.

Actual EPS vs Estimated EPS

How EPS can be helpful

Understanding the true essence of Earnings Per Share (EPS) for a company can be a complex endeavor. EPS, essentially a measure of a company's profitability on a per-share basis, is often used by investors as a barometer of financial health. However, it's crucial to recognize that EPS can be subject to manipulation through various accounting techniques and management strategies.

MNMD Earnings History

Report DateActualForecastSurprise Factor
Aug 13, 2024-0.48-0.3+60.00%
May 08, 2024-0.6-0.66-9.09%
May 02, 2024-0.61-0.66-7.58%
Feb 28, 2024-0.59-0.48+22.92%
Feb 13, 2024-0.59-0.46+28.26%
Nov 02, 2023-0.53-0.65-18.46%

After EPS - Where did the stock go?

Earning DateClosing Price Before EarningBefore Closing Price ChangeNext Day Closing PriceNext Day Price ChangeOn 7th Day Closing PriceOn 7th Day Closing Change
No Data

Frequently Asked Questions

Is MNMD stock getting favorable reviews from Wall Street analysts?

Brokerage firms have given MNMD stock an average recommendation of Buy. 33 analysts have given their ratings to MNMD out of which 12 analysts have given strong buy call, 21 analysts have given buy call, 0 analysts rate it hold, 0 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of $28.61 gives the stock implied upside of roughly 413.57% over the next year or so.

What have analysts suggested for MNMD highest price target?

Analysts suggest MNMD's stock price would rise to a high of $75.00.

What is the lowest price target analysts expect for MNMD over the next year?

Within the next 12 months, analysts predict the MNMD stock price could move to $3.00.

What is the average target price for MNMD?

MNMD stock has an average analyst estimate of $28.61.

At its current price, how far is MNMD from its average target price?

MNMD shares are currently trading 413.57% above this price target.

What were MNMD’s actual earnings per share for the recent quarter?

Its quarterly earnings per share (EPS) came in at -$0.48 versus consensus estimates of -$0.30, and above the comparable year-ago quarter’s EPS of -$0.59.

What are the current estimates for quarterly and annual earnings per share?

MNMD's forecasts by analysts estimating quarterly EPS at -$0.28 and $16.97 for the whole year.

What has MNMD's growth been in the past five years and what is expected in the next five years?

The analysts have projected N/A EPS growth for MNMD in the next five years, compared to growth rates of 2.29% in the past five years.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph